Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations

Allergy and Asthma Proceedings, 05/15/2012

Adverse effects include weight gain, virilization, increased hair growth, hypercholesterolemia, depression, and liver adenomas. C1–esterase inhibitor (C1 INH)–nf reduces frequency of attacks and is well tolerated. Each patient with hereditary angioedema (HAE) has unique needs, based on the nature and frequency of past attacks, proximity to a medical center, occupation, and the patient's wishes. These factors should be used to create a patient–centered approach to management of HAE.

Print Article Summary Cat 2 CME Report